ATAI Life Sciences AG 3
3 · IntelGenx Technologies Corp. · Filed May 24, 2021
Insider Transaction Report
Form 3
ATAI Life Sciences B.V.
10% Owner
Holdings
Warrant (Right to Buy)
→ Common Stock, $0.00001 par valueWarrant (Right to Buy)
Exp: 2024-05-14→ Common Stock, $0.00001 par value (130,000,000 underlying)- 37,300,000
Common Stock, $0.00001 par value per share
Warrant (Right to Buy)
Exercise: $0.35Exp: 2024-05-14→ Common Stock, $0.00001 par value (22,380,000 underlying)
Footnotes (4)
- [F1]See Exhibit 99.1
- [F2]See Exhibit 99.1
- [F3]See Exhibit 99.1
- [F4]See Exhibit 99.1